Log In
Print
BCIQ
Print
Print this Print this
 

Yisaipu

  Manage Alerts
Collapse Summary General Information
Company Shanghai CP Guojian Pharmaceutical Co. Ltd.
DescriptionRecombinant tumor necrosis factor receptor
Molecular Target Tumor necrosis factor (TNF) receptor 2 (TNFR2)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today